We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Safety May Be Sacrificed in Meeting PDUFA Deadlines
Drug Safety May Be Sacrificed in Meeting PDUFA Deadlines
September 1, 2006
The FDA’s rush to meet drug review timelines under the Prescription Drug User Fee Act (PDUFA) may lead to more postmarketing safety problems, a Harvard University professor said.